Dr Christopher Gallen
Guest ContributorJuly 16, 2004
Dr Christopher Gallen has been appointed president and CEO of Vancouver-based Neuromed Technologies Inc, a private biopharmaceutical firm focused on drugs for chronic pain. He replaces founding president
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.